Lantus and Eloxatin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Lantus (insulin glargine recombinant) and Eloxatin (oxaliplatin). Common drug interactions include vomiting among females and cancer pain among males.

The phase IV clinical study analyzes what interactions people have when they take Lantus and Eloxatin. It is created by eHealthMe based on reports of 20 people who take the same drugs from the FDA, and is updated regularly.

What is Lantus?

Lantus has active ingredients of insulin glargine recombinant. It is often used in diabetes. eHealthMe is studying from 191,782 Lantus users. Check the latest studies of Lantus.

What is Eloxatin?

Eloxatin has active ingredients of oxaliplatin. eHealthMe is studying from 7,092 Eloxatin users. Check the latest studies of Eloxatin.

On Jul, 12, 2026

20 people who take Lantus and Eloxatin together, and have interactions are studied.

What are the common drug interactions of Lantus and Eloxatin, by gender? *:

female:

Vomiting
Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
Depressed level of consciousness
Dyspnoea (difficult or laboured respiration)
Grand mal convulsion (a type of generalized seizure that affects the entire brain)
Nausea (feeling of having an urge to vomit)
Acute respiratory failure
Aggression
Agitation (state of anxiety or nervous excitement)
Anaemia (lack of blood)

male:

Cancer pain
Decreased appetite
Cardiac failure congestive
Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
Cyanosis (lack of oxygen in body leads to blue appearance of skin ,mucous membrane nails)
Death
Dehydration (dryness resulting from the removal of water)
Disease progression
Dry skin
Dysphagia (a condition in which swallowing is difficult or painful)

What are the common drug interactions of Lantus and Eloxatin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Cancer pain
Hyperglycaemia (high blood sugar)
Lethargy (tiredness)
Dysphagia (a condition in which swallowing is difficult or painful)
Haemorrhage (bleeding)
Oesophagitis (inflammation of oesophagus)
Oropharyngeal pain
Pharyngitis (inflammation of the pharynx, causing a sore throat)

60+:

Dyspnoea (difficult or laboured respiration)
Vomiting
Agitation (state of anxiety or nervous excitement)
Anaemia (lack of blood)
Asthenia (weakness)
Bladder dilatation
Cardiac arrest
Chest pain
Constipation
Diastolic dysfunction

What are the existing conditions these people have? *

Pancreatic Carcinoma (pancreatic cancer): 4 people, 20.00%
Type 2 Diabetes: 3 people, 15.00%
Pain: 3 people, 15.00%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 2 people, 10.00%
Pancreatic Carcinoma Metastatic (pancreatic cancer- metastatic): 2 people, 10.00%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 10.00%
Blood Iron Decreased: 2 people, 10.00%
Pancreatic Neuroendocrine Tumor: 1 person, 5.00%
Pancreatic Carcinoma Stage Iv (pancreatic cancer stage iv): 1 person, 5.00%
Nausea (feeling of having an urge to vomit): 1 person, 5.00%

* Approximation only. Some reports may have incomplete information.

Do you take Lantus and Eloxatin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously